For patients without clear indication for b12 supplementation, using a compounded combination means paying extra for an additive that may provide no benefit
Loading and maintenance phases Some peptides benefit from loading phases with higher initial doses, followed by reduced maintenance dosing
Both treatments were administered in double-blind placebo-controlled randomized crossover studies
Goldman Sachs Research estimates that GLP-1 obesity drug prescriptions could reach 30 million Americans by 2028 if coverage barriers are resolved, representing USD 150+ billion in additional annual market potential beyond current diabetes-only prescribing
While GLP-1 agonists alone have a low intrinsic risk of causing low blood sugar, this risk increases significantly when they are used in combination with insulin or sulphonylureas, as noted in product SmPCs [11] [9] Possibly associated with rapid weight loss : Significant weight reduction might potentially lead to electrolyte imbalances or nutritional deficiencies that could contribute to tremor, though this mechanism is not well-established Coincidental : Tremors may develop independently of medication use, particularly in older adults or those with other underlying conditions If you develop new or worsening hand tremors whilst taking a GLP-1 agonist, it is essential to discuss this with your healthcare provider rather than assuming a direct causal relationship
